Skip to content

Investigation of the Effects of Parent-Supported Psychosocial Development Program on 1-3 Year-Old Children

Investigation of the Effects of Parent-Supported Psychosocial Development Program on 1-3 Year-Old Children

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06951165
Enrollment
43
Registered
2025-04-30
Start date
2024-11-01
Completion date
2025-02-28
Last updated
2025-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Children, Parent Child Relationships, Psychosocial Development

Keywords

psychosocial development, Parent, children

Brief summary

Growth within the periods of 1-3 years of age, children's physical, psychosocial, It has an important place in terms of cognitive and language development. During this period, children can develop They gain very important skills for their development. In this context, the research the aim of the parent-supported psychosocial development programme for 1-3 year olds is to examine the effects on children. The research is a randomised parallel controlled study. The sample of the study consisted of parents with children between the ages of 1-3 years will constitute. In the study, parents were randomised to the intervention (n:41) and control (n:41) groups. Parent-supported psychosocial development programme will be applied to the intervention group. The control group will be will continue their routine childcare. The data will be analysed with data collection tools will be collected at the same time for both groups. Data collection phase at the end of the programme After the end of the programme, all parents from the control group who requested the training were given the programme. will be applied in the same way.

Detailed description

Growth within the periods of 1-3 years of age, children's physical, psychosocial, It has an important place in terms of cognitive and language development. During this period, children can develop They gain very important skills for their development. In this context, the research the aim of the parent-supported psychosocial development programme for 1-3 year olds is to examine the effects on children. The research is a randomised parallel controlled study. The sample of the study consisted of parents with children between the ages of 1-3 years will constitute. In the study, parents were randomised to the intervention (n:41) and control (n:41) groups. Parent-supported psychosocial development programme will be applied to the intervention group. The control group will be will continue their routine childcare. The data will be analysed with data collection tools will be collected at the same time for both groups. Data collection phase at the end of the programme After the end of the programme, all parents from the control group who requested the training were given the programme. will be applied in the same way.

Interventions

BEHAVIORALParent Supported Psychosocial Development Programme

A six-module online program was developed for parents of children ages 1 to 3. The program was provided to parents as a PDF, one module per week, and each module was discussed online.

Sponsors

Kastamonu University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
1 Years to 3 Years
Healthy volunteers
No

Inclusion criteria

1. Being a parent of a child between the ages of 1-3 2. Having a tablet, computer or smartphone with internet access

Exclusion criteria

1. Using psychiatric medication 2. Being a parent of a child diagnosed with any behavioral problem

Design outcomes

Primary

MeasureTime frameDescription
The level of psychosocial support of parents of children with autism will be measuredfour weekThe level of psychosocial support of children's parents will be measured with the Psychosocial Status Assessment Scale.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 8, 2026